Abstract
Vibrio cholerae is a facultative human pathogen responsible for the cholera disease which infects millions of people worldwide each year. V. cholerae is a natural inhabitant of aquatic environments and the infection usually occurs after ingestion of contaminated water or food. The virulence factors of V. cholerae have been extensively studied in the last decades and include the cholera toxin and the coregulated pilus. Most of the virulence factors of V. cholerae belong to the secretome, which corresponds to all the molecules secreted in the extracellular environment such as proteins, exopolysaccharides, extracellular DNA or membrane vesicles. In this chapter, we review the current knowledge of the secretome of V. cholerae and its role in virulence, colonization and resistance. In the first section, we focus on the proteins secreted through conventional secretion systems. The second and third sections emphasize on the membrane vesicles and on the secretome associated with biofilms.
Keywords
- Vibrio cholerae
- secretome
- secretion system
- membrane vesicles
- biofilm
1. Introduction
2. Secretion systems
2.1 Type II secretion system for virulence and environmental fitness
The type II secretion system (T2SS) shares many structural characteristics with the type IV pilus (T4P) and is conserved among Gram-negative bacteria for delivery of colonization and virulence factors in the extracellular milieu [4, 5]. In
The growth defect of mutants lacking essential components or regulators of the T2SS shows that it is a vital component for
2.1.1 Structure and secretion through the T2SS
The structural components [5] and secreted proteins [4] of the T2SS have recently been the object for reviews. Briefly, the T2SS assembles in 4 complexes; (i) the secretin, a pore located in the outer membrane, (ii) the inner membrane anchoring platform, (iii) the intracytoplasmic ATPase complex and (iv) the pseudopilus. Even though the exact sequence of biogenesis is still unknown, a general pathway of assembly has been suggested.
The targeted proteins with signal peptides are firstly translocated to the periplasm by Sec or Tat, where they are assembled to acquire a secretion competent conformation [12, 13]. Then, it has been proposed that they bind to the pseudopilin trimeric tip and to the inner membrane platform. This interaction activates the ATPase hydrolysis activity, thus the pseudopilus elongation by addition of pseudopilin subunits and leads to the thrust of the secreted protein through the secretin channel as a piston [5]. It has been proposed that the signals for T2SS transportation are dependent on the protein conformation on the N-terminal signal peptides, but they have not been clearly identified yet [14].
2.1.2 Genes and regulation
The T2SS apparatus is composed of a dozen types of proteins, which are encoded on the
2.1.3 Secreted proteins
In
In the aquatic environment, after binding to zooplankton, copepods and insect egg masses,
Besides chitin, collagen can also be used as carbon source by
After the ingestion,
A second important component of the mucinase complex is the neuramidase (VCNA - VC1784). The sialidase, or neuraminidase, is encoded on the pathogenicity island of every toxigenic
The CT (VC1456-57) is an AB5 toxin secreted by the T2SS in the intestinal lumen, which represents the main virulence factor of
Prior to GM1 binding, the CT must be processed by extracellular proteases to be activated. These proteases are therefore important for virulence and colonization. Besides their capacity to activate the toxin, they have a role in finding a substrate (modification of integrin) and nutrients, and in deactivating host defense mechanisms. Among the T2SS secreted proteins, 3 serine proteases with 30% homology between them have been identified, the
Other virulence factors secreted by the T2SS have been identified in
The cytolytic toxin cytolysin/hemolysin A (VCC or HlyA - VCA0219), is secreted by the T2SS [6]. All
Leucine aminopeptidase (Lap - VCA0812) and aminopeptidase (LapX - VCA0813) are other secreted proteases using T2SS [6]. Lap is a zinc dependant metallo-exopeptidase that cleaves leucin in N-terminal position, while the role of LapX remains unknown [61]. Both Lap and LapX have no role in virulence in a
Finally, several proteins involved in biofilm formation and dissemination are also secreted by the T2SS in
2.2 Type VI secretion system for competition and DNA acquisition
The type VI secretion system (T6SS) is a versatile syringe-like apparatus with homology to the phage T4 and produced by more than 25% Gram-negative bacteria that, upon contact with a target cell, punctures its cell wall, allowing translocation of toxic effectors directly into the neighboring cells [64, 65]. The cellular targets of these effectors are multiple; peptidoglycan, actin, cellular membrane, nucleic acids and immune system components, for instance [66]. As the target cells release their DNA into the extracellular milieu upon lysis, another function of the T6SS is to capture the extracellular DNA (eDNA) in order to acquire new features such as antibiotic resistance factors and new effectors or immunity proteins [67]. Bacteria use this device as a competition effector to take over the environmental niche and a single bacterium can possess as much as 6 different types of T6SS [65]. In
2.2.1 Structure and secretion through the T6SS
The T6SS is anchored in the cell membrane and contains 4 distinct domains; (i) the membrane complex, (ii) the baseplate, (iii) the contractile sheath and (iv) the syringe. The current knowledge on the structure of the T6SS have been reviewed elsewhere [64].
Valine glycine rich proteins G 1, 2 and 3 (VgrG1-3) and a single proline-alanine-alanine-arginine repeated motif protein (PAAR) form the tip of the syringe [69]. There are multiple PAAR proteins in
2.2.2 Genes and regulation
In
The complexity of the apparatus and its organization require a fine regulation to insure its efficiency and recycling. The transcriptional regulation of the T6SS in
2.2.3 Secreted proteins
As mentioned before, the T6SS apparatus carries toxic effectors directly into the target bacterial or eukaryotic cells. A single contraction event allows the translocation of many of these effectors at the same time into the target cell [69]. The cellular targets for these effectors are multiple; they go from peptidoglycan to cellular membrane, actin and nucleic acids [64]. To protect themselves against the toxic effectors they produce, bacterial cells express immunity proteins, which brings the notion of strains compatibility (for more information see: [81]). The secreted effectors and structure components can be reused by recipient cells to form a new T6SS [82].
Hcp is one of the proteins transported by the T6SS into the target cell, in addition to be part of its structure by forming the inner tube and serving as a chaperone to the effector molecules [83]. Hcp is encoded by two different yet functional genes (VC1415; VCA0017) producing the same protein [68, 84]. Both genes must be knocked out to suppress the T6SS activity [68]. Hcp is co-expressed with HlyA, and its secretion was observed before the discovery of the T6SS [84].
Similarly to Hcp, the VgrG proteins (VC1416; VCA0018; VCA0123) are part of the T6SS structure and are secreted into the target cell upon contraction of the T6SS [68, 85]. VgrG-1 has an actin cross-linking activity in eukaryotic cells, thus preventing cytoskeleton reorganization and phagocytosis [86]. VgrG-2 is homologous to VgrG-1, but without a functional C-terminal effector domain [85]. Both appear to be essential for secretion of other T6SS components as a mutational inactivation of one of these gene makes the mutant unable to secrete any T6SS-dependant effectors [85]. Since its toxicity is exclusive to eukaryotic cells, no immunity coupled protein is required against VgrG-1. The VgrG-3 protein is known to be active against other bacteria by hydrolyzing peptidoglycan with its lysozyme-like domain, after a translocation to the periplasm [85, 87]. It might also have a muramidase activity, which could be useful in its aquatic niche to gain access to chitin or in infection to cross mucin [88]. TsiV3 (VCA0124) acts as the antitoxin for VgrG-3 by biding to it and prevents the degradation of the cell wall in the predator bacteria [87]. Thus, VgrG-3 might be important for infection by killing gut microbiota and by hydrolysing mucin.
The PAAR proteins (VCA0284; VCA0105), along with VgrGs, form the tip of the syringe of T6SS, bind the effectors and are therefore essential for T6SS effectors’ secretion. There are two proteins with a PAAR domain in
The cargo effector VasX (VCA0020) acts as a colicin and targets the inner bacterial membrane or eukaryotic membrane in which it is believed to form pores, increase permeability and lead to its disruption [89]. It is encoded downstream of Hcp-2 and VgrG-2 and is regulated by VasH [89]. Its immunity coupled protein is TsiV2 (VCA0021) [88]. The VasW (VCA0019) protein encoded right upstream VasX is an adaptor protein that plays a role in secretion of VasX and an accessory role to VasX bactericidal activity [90].
The type six effector Lipase (TseL - VC1418) is another cargo effector and its secretion depends on the presence of VgrG-3. It carries a phospholipase domain that is believed to cause damage to cell membranes in both eukaryotic and prokaryotic cells [88, 91]. Its immunity coupled protein is TsiV1 (VC1419).
The type six effector Hydrolase (TseH - VCA0285) is encoded next to the PAAR protein and its secretion is dependant of the T6SS [92]. It has been shown that TseH is able to degrade peptidoglycan, a main component of the bacterial cell wall, by hydrolysis and would therefore make it an important effector as for interbacterial competition. Its immunity coupled protein is the type six immunity hydrolase (TsiH - VCA0286), which prevents cell wall degradation.
Recently, another lipase, the Type VI lipase effector
It is most likely that, as genome analysis of more
2.3 Type I secretion system, a tool for auxiliary toxins secretion
The type I secretion system (T1SS) is used by Gram-negative bacteria to secrete, in a one-step process using ATP, proteins directly into the extracellular milieu.
2.3.1 Structure and secretion through the T1SS
The most studied T1SS is the hemolysin A associated T1SS (HlyA-T1SS) from
The secreted proteins carry a C-terminal secretion signal sensed by the inner membrane proteins upon binding [95]. The porin TolC is then recruited to the complex, and the proteins pass through the HlyB and HlyD channel. The binding of TolC to the inner membrane complex allows its opening and the secretion of the protein to the extracellular milieu, whereafter TolC leaves the complex [94]. As the inner membrane proteins bind to specific substrates, the TolC can be used by multiple T1SS within a cell [96]. The secreted proteins have a functional domain in N-terminal and are secreted shortly after their translation in their unfolded state. In
2.3.2 Genes and regulation
The
2.3.3 Secreted proteins
The repeat in toxin (RTX) proteins are a class of proteins exclusively secreted by the T1SS [99]. They include the HlyA of
One T1SS has been described in
Three other T1SS could be found in
2.4 Type III secretion system for colonization and injection of effectors into eukaryotic host cells
The Type III secretion system (T3SS) is a multicomponent device translocating various effectors directly into the neighbouring eukaryotic host cells and is found in many
2.4.1 Structure and secretion through the T3SS
The T3SS is a multicomponent apparatus spawning both bacterial membranes. While the effectors’ secretion through T3SS is Sec independent, the translocation of the membrane components of the injectosome requires it [113]. The T3SS uses ATP for the active translocation of the effectors through both bacterial membranes directly into host cell cytoplasm. The T3SS consists of an injectosome with structural and genetic homology to the flagellum and a molecular syringe, the structure has been reviewed elsewhere [113]. In brief, the syringe connects the membrane complex to the host cell cytoplasm. It is composed of (i) a basal needle, (ii) a tip and, at its end, (iii) a translocation pore. The membrane complex is composed of an assembly of concentric rings creating a channel through both bacterial membranes. It includes an outer membrane ring connected, in the periplasm, to the inner membrane ring, in addition to a cytoplasmic portion, made of a cytoplasmic ring and an ATPase complex. The exact T3SS assembly in
2.4.2 Genes and regulation
While some
2.4.3 Secreted proteins
The presence of T3SS in non O1/O139 strains leads to intestinal epithelium damages, such as alteration of the brush border and disruption, as seen in the infant rabbit model of infection [112]. It is the result of the translocation of many effectors into the eukaryotic host cytoplasm by the T3SS. In
A total of 11 proteins that use the T3SS for their secretion have been identified by using a FRET technique to visualize the translocation of proteins in HeLa cells, including an effector specific to
Another of the secreted effectors is VopE (A33_1662) [121]. VopE is translocated to the mitochondria after its secretion by the T3SS, where it acts as a GTPase-activating protein. Its presence in the mitochondria intervenes with the normal process of Rho GTPases Miro1 and 2, thus with the immune response using mitochondrial signalisation pathways [121, 122]. Along with VopF, VopE would lead to the loosening of the tight junctions, a primordial structure of the intestinal epithelium [119]. VopM (A33_1684) is another effector secreted by the T3SS that leads to actin stress fibers formation and brush border effacement [110].
Other effectors have been identified, but their function remains unclear, such as VopZ (A33_1704), VopW (A33_1690), VopA (A33_1680), VopG (A33_1697), VopI (A33_1687), VopY (A33_1700), VopH (A33_1678) and VopK (A33_1699) [110, 114]. VopW is known as a hydrophilic translocator that would both have structural and effector roles [114]. Despite the lack of information, a study on multiple effectors brought some light on their potential role in infection [110]. It stated that VopA, VopM, VopW and VopH seemed to be required for intestinal colonization in infant mouse model of infection, as mutants of these effectors where not recovered from infected animals. VopA could also have a role in adhesion to the intestinal cells in the early stages of infection. Along with VopH, VopI and VopW, VopA could be part of the structural apparatus as it is essential for other effectors secretion.
2.5 Type IV secretion system, a crucial virulence factor
Three T4Ps can be found at the surface of
2.5.1 The toxin coregulated pilus
The pandemic virulence potential of
2.5.2 The mannose sensitive hemagglutinin pilus
MSHA is produced by O1 El Tor and O139 strains, but not by the O1 classical strains, and is important for adhesion to chitinous surface and biofilm formation, although it does not seem to play a role in virulence nor colonization in humans [27, 31, 126, 128]. Its filament is composed of the single major pilin MshA [129]. The dynamic of retraction/polymerization of the MSHA is controlled by c-di-GMP [129].
2.5.3 The chitin regulated pilus
The third T4P identified in
2.6 Other secreted molecules
The cholix toxin (ChxA) is a eukaryotic elongation factor-2 specific ADP-rybosyl transferase that induces cell death [133]. ChxA is produced by many
Accessory cholera enterotoxin (Ace - VC1459) and zonula occludens toxin (Zot - VC1458) are accessory toxins that are both encoded near the CT genes on the CTXφ phage [136, 137]. Zot leads to the disruption of the tight junctions between intestinal epithelial cells, an important structure in the intestinal permeability [138, 139]. It is translocated and anchored in the outer membrane and has two functional domains. The N-terminal domain is important for CTXφ phage’s morphogenesis and the C-terminal domain is cleaved by proteases. Once released into the intestinal lumen, the C-terminal domain acts as a toxin [139, 140]. Thus, Zot does not employ a conventional secretion system for its release into the extracellular milieu. Regarding Ace, it leads to fluid secretion in rabbit ileal loop model by unbalancing calcium secretion and the secretion mechanism has not been determined yet [138].
3. Membrane vesicles, the type 0 secretion system
Most bacteria, including Gram-negative and Gram-positive bacteria, release MV, also known as the type 0 secretion system [141]. Different types of MV can be produced including the outer membrane vesicles (OMV), the outer-inner membrane vesicles (OIMV), the cytoplasmic membrane vesicles (CMV) and the tube-shaped membranous structures (TSMS). The different types of MV differ in their composition and their biogenesis mechanisms, which will not be presented here since they have already been reviewed elsewhere [142].
3.1 Membrane vesicles and resistance
A role for the MV in antimicrobial peptides (AMP) resistance has been reported in several Gram-negative bacteria including
Besides AMP, MV are also involved in serum resistance in
A role of the MV in resistance to bacteriophages has also been demonstrated in
3.2 Membrane vesicles and biofilm
A significant part of antimicrobial resistance is associated with the biofilm lifestyle of bacteria. The bacteria growing in a biofilm are up to 1000 times more resistant to antimicrobials and disinfectants than their planktonic counterparts [155]. It has been demonstrated that MV are involved in the formation of biofilms in several Gram-negative bacteria [156]. In
3.3 Membrane vesicles and virulence
The MV can also carry virulence factors including the CT, the major virulence factor of
Besides the CT, other biologically active virulence factors can also be transported to the host cells through MV. It is the case for HA/P and VesC [160], PrtV metalloprotease [56] and the VCC [161]. Therefore, the MV of
4. Biofilms and flagella
Most of the bacteria, including pathogens, form biofilm to survive and persist in different environments. Biofilms are organized bacterial communities attached to a surface and producing a matrix.
4.1 From motility to initial adhesion
Planktonic
Additionally, FrhA (hemagglutinin) and CraA (adhesin) secreted through the T1SS are involved in adhesion and biofilm formation (see T1SS section). The expression of both
4.2 Biofilm maturation
Once attached,
Shortly after VPS secretion has been initiated, the sequential secretion of the 3 major biofilm matrix proteins through the T2SS occurs. The first matrix protein to be secreted is RbmA, followed by Bap1 and RbmC [176]. More specifically, RmbC has a role in maintaining and stabilizing the biofilm [177]. A study using mutants lacking RbmC and its homolog Bap1 showed a change of colonial morphology and the loss of biofilm formation capacity [177, 178]. On the other hand, RbmA controls the structure of the biofilm [9, 179].
Growth of the biofilm is ensured by two different processes: (i) the bacteria inside the matrix are dividing inside an envelope formed by the VPS, RbmC and Bap1 [176] and (ii) new bacteria are recruited inside the biofilm. This recruitment requires the cleavage of the N-terminal domain of RbmA by PrtV. Once cleaved, RbmA can bind bacterial cells that are not producing VPS (planktonic) and recruits them into the biofilm [180]. Since MV have been observed in the biofilm matrix and PrtV can be associated to the surface of the MV, it is possible that MV play an important role in biofilm maturation in
Besides VPS, proteins and MV, a significant amount of eDNA is entrapped in the biofilm matrix. The roles of eDNA in bacterial physiology have been reviewed elsewhere and include nutrient source, horizontal gene transfer and adherence [183]. Recently, a role in the tridimensional matrix structure of the biofilm in
4.3 Biofilm dispersion and detachment
Biofilm dispersal is a complex process by which bacteria actively succeed to evade biofilm matrix [186]. Conversely to adhesion and biofilm maturation, little is known about the dispersion process of
5. Conclusion
Over the last decades, numerous studies have focused on the secreted molecules and secretion systems used by
The recent characterization of the MakA toxin secretion through the fT3SS [168] and the numerous studies on the T6SS since its discovery 15 years ago [68] clearly demonstrate that there is still work to do on the secretome and secretion systems in
The regulation of the secretion systems and their cargo molecules is a complex process. It involves numerous regulators that can be activated or repressed depending on the detection of specific intracellular and extracellular signals. So far, most of the studies aiming to decipher the regulation pathways have been performed under laboratory conditions. The featuring of conditions that characterize the intestinal environment before and during diarrhea, including the peristaltic movement, anaerobia, the presence of the microbiota, water efflux and high osmolarity, is likely to modify
Acknowledgments
This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery grant number RGPIN-2017-05322. AMD received financial support from the Fonds de recherche du Québec en Santé, doctoral training scholarship #290352.
References
- 1.
Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007;7(8):521-530 - 2.
Sengupta C, Mukherjee O, Chowdhury R. Adherence to Intestinal Cells Promotes Biofilm Formation in Vibrio cholerae . J Infect Dis. 2016;214(10):1571-1578 - 3.
Vanden Broeck D, Horvath C, De Wolf MJ. Vibrio cholerae : cholera toxin. Int J Biochem Cell Biol. 2007;39(10):1771-1775 - 4.
Sikora AE. Proteins secreted via the type II secretion system: smart strategies of Vibrio cholerae to maintain fitness in different ecological niches. PLoS Pathog. 2013;9(2):e1003126 - 5.
Korotkov KV, Sandkvist M, Hol WG. The type II secretion system: biogenesis, molecular architecture and mechanism. Nat Rev Microbiol. 2012;10(5):336-351 - 6.
Sikora AE, Zielke RA, Lawrence DA, Andrews PC, Sandkvist M. Proteomic analysis of the Vibrio cholerae type II secretome reveals new proteins, including three related serine proteases. J Biol Chem. 2011;286(19):16555-16566 - 7.
Sandkvist M, Michel LO, Hough LP, Morales VM, Bagdasarian M, Koomey M, et al. General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae . J Bacteriol. 1997;179(22):6994-7003 - 8.
Sikora AE, Lybarger SR, Sandkvist M. Compromised outer membrane integrity in Vibrio cholerae Type II secretion mutants. J Bacteriol. 2007;189(23):8484-8495 - 9.
Johnson TL, Fong JC, Rule C, Rogers A, Yildiz FH, Sandkvist M. The Type II secretion system delivers matrix proteins for biofilm formation by Vibrio cholerae . J Bacteriol. 2014;196(24):4245-4252 - 10.
Lybarger SR, Johnson TL, Gray MD, Sikora AE, Sandkvist M. Docking and assembly of the type II secretion complex of Vibrio cholerae . J Bacteriol. 2009;191(9):3149-3161 - 11.
Johnson TL, Abendroth J, Hol WG, Sandkvist M. Type II secretion: from structure to function. FEMS Microbiol Lett. 2006;255(2):175-186 - 12.
Voulhoux R, Ball G, Ize B, Vasil ML, Lazdunski A, Wu LF, et al. Involvement of the twin-arginine translocation system in protein secretion via the type II pathway. EMBO J. 2001;20(23):6735-6741 - 13.
Hofstra H, Witholt B. Kinetics of synthesis, processing, and membrane transport of heat-labile enterotoxin, a periplasmic protein in Escherichia coli. J Biol Chem. 1984;259(24):15182-15187 - 14.
Connell TD, Metzger DJ, Lynch J, Folster JP. Endochitinase is transported to the extracellular milieu by the eps-encoded general secretory pathway of Vibrio cholerae . J Bacteriol. 1998;180(21):5591-5600 - 15.
Zielke RA, Simmons RS, Park BR, Nonogaki M, Emerson S, Sikora AE. The type II secretion pathway in Vibrio cholerae is characterized by growth phase-dependent expression of exoprotein genes and is positively regulated by sigmaE. Infect Immun. 2014;82(7):2788-2801 - 16.
Sloup RE, Konal AE, Severin GB, Korir ML, Bagdasarian MM, Bagdasarian M, et al. Cyclic Di-GMP and VpsR Induce the Expression of Type II Secretion in Vibrio cholerae . J Bacteriol. 2017;199(19) - 17.
Benktander J, Angstrom J, Karlsson H, Teymournejad O, Linden S, Lebens M, et al. The repertoire of glycosphingolipids recognized by Vibrio cholerae . PLoS One. 2013;8(1):e53999 - 18.
Wong E, Vaaje-Kolstad G, Ghosh A, Hurtado-Guerrero R, Konarev PV, Ibrahim AF, et al. The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces. PLoS Pathog. 2012;8(1):e1002373 - 19.
Stauder M, Huq A, Pezzati E, Grim CJ, Ramoino P, Pane L, et al. Role of GbpA protein, an important virulence-related colonization factor, for Vibrio cholerae’s survival in the aquatic environment. Environ Microbiol Rep. 2012;4(4):439-445 - 20.
Kirn TJ, Jude BA, Taylor RK. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature. 2005;438(7069):863-866 - 21.
Bhowmick R, Ghosal A, Das B, Koley H, Saha DR, Ganguly S, et al. Intestinal adherence of Vibrio cholerae involves a coordinated interaction between colonization factor GbpA and mucin. Infect Immun. 2008;76(11):4968-4977 - 22.
Keyhani NO, Roseman S. Physiological aspects of chitin catabolism in marine bacteria. Biochim Biophys Acta. 1999;1473(1):108-122 - 23.
Finne J, Breimer ME, Hansson GC, Karlsson KA, Leffler H, Vliegenthart JF, et al. Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem. 1989;264(10):5720-5735 - 24.
Zampini M, Pruzzo C, Bondre VP, Tarsi R, Cosmo M, Bacciaglia A, et al. Vibrio cholerae persistence in aquatic environments and colonization of intestinal cells: involvement of a common adhesion mechanism. FEMS Microbiol Lett. 2005;244(2):267-273 - 25.
Jude BA, Martinez RM, Skorupski K, Taylor RK. Levels of the secreted Vibrio cholerae attachment factor GbpA are modulated by quorum-sensing-induced proteolysis. J Bacteriol. 2009;191(22):6911-6917 - 26.
Finkelstein RA, Boesman-Finkelstein M, Holt P. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A. 1983;80(4):1092-1095 - 27.
Stauder M, Vezzulli L, Pezzati E, Repetto B, Pruzzo C. Temperature affects Vibrio cholerae O1 El Tor persistence in the aquatic environment via an enhanced expression of GbpA and MSHA adhesins. Environ Microbiol Rep. 2010;2(1):140-144 - 28.
Mandal S, Chatterjee NS. Vibrio cholerae GbpA elicits necrotic cell death in intestinal cells. J Med Microbiol. 2016;65(8):837-847 - 29.
Loose JS, Forsberg Z, Fraaije MW, Eijsink VG, Vaaje-Kolstad G. A rapid quantitative activity assay shows that the Vibrio cholerae colonization factor GbpA is an active lytic polysaccharide monooxygenase. FEBS Lett. 2014;588(18):3435-3440 - 30.
Garay E, Arnau A, Amaro C. Incidence of Vibrio cholerae and related vibrios in a coastal lagoon and seawater influenced by lake discharges along an annual cycle. Appl Environ Microbiol. 1985;50(2):426-430 - 31.
Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, Schoolnik GK. The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A. 2004;101(8):2524-2529 - 32.
Bhowmick R, Ghosal A, Chatterjee NS. Effect of environmental factors on expression and activity of chitinase genes of vibrios with special reference to Vibrio cholerae . J Appl Microbiol. 2007;103(1):97-108 - 33.
Mondal M, Nag D, Koley H, Saha DR, Chatterjee NS. The Vibrio cholerae extracellular chitinase ChiA2 is important for survival and pathogenesis in the host intestine. PLoS One. 2014;9(9):e103119 - 34.
Li X, Wang LX, Wang X, Roseman S. The chitin catabolic cascade in the marine bacterium Vibrio cholerae : characterization of a unique chitin oligosaccharide deacetylase. Glycobiology. 2007;17(12):1377-1387 - 35.
Zhang YZ, Ran LY, Li CY, Chen XL. Diversity, Structures, and Collagen-Degrading Mechanisms of Bacterial Collagenolytic Proteases. Appl Environ Microbiol. 2015;81(18):6098-6107 - 36.
Park BR, Zielke RA, Wierzbicki IH, Mitchell KC, Withey JH, Sikora AE. A metalloprotease secreted by the type II secretion system links Vibrio cholerae with collagen. J Bacteriol. 2015;197(6):1051-1064 - 37.
Benitez JA, Silva AJ. Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities. Toxicon. 2016;115:55-62 - 38.
Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae . Proc Natl Acad Sci U S A. 2002;99(5):3129-3134 - 39.
Vance RE, Zhu J, Mekalanos JJ. A constitutively active variant of the quorum-sensing regulator LuxO affects protease production and biofilm formation in Vibrio cholerae . Infect Immun. 2003;71(5):2571-2576 - 40.
Booth BA, Boesman-Finkelstein M, Finkelstein RA. Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin. Infect Immun. 1984;45(3):558-560 - 41.
Silva AJ, Leitch GJ, Camilli A, Benitez JA. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera. Infect Immun. 2006;74(4):2072-2079 - 42.
Wu Z, Nybom P, Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol. 2000;2(1):11-17 - 43.
Finkelstein RA, Boesman-Finkelstein M, Chang Y, Hase CC. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun. 1992;60(2):472-478 - 44.
Moustafa I, Connaris H, Taylor M, Zaitsev V, Wilson JC, Kiefel MJ, et al. Sialic acid recognition by Vibrio cholerae neuraminidase. J Biol Chem. 2004;279(39):40819-40826 - 45.
Galen JE, Ketley JM, Fasano A, Richardson SH, Wasserman SS, Kaper JB. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun. 1992;60(2):406-415 - 46.
Crennell S, Garman E, Laver G, Vimr E, Taylor G. Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure. 1994;2(6):535-544 - 47.
Finkelstein RA, Mukerjee S, Rudra BC. Demonstration and Quantitation of Antigen in Cholera Stool Filtrates. J Infect Dis. 1963;113:99-104 - 48.
Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 1996;272(5270):1910-1914 - 49.
Davis BM, Lawson EH, Sandkvist M, Ali A, Sozhamannan S, Waldor MK. Convergence of the secretory pathways for cholera toxin and the filamentous phage, CTXphi. Science. 2000;288(5464):333-335 - 50.
Chaudhuri K. Structure, Genetics, and Mode of Disease of Cholera Toxin. In: Gopalakrishnakone P. B-MM, Llewellyn L., Singh B., editor. Biological Toxins and Bioterrorism. Toxinology. 1. Dordrecht: Springer; 2014. p. 3-27 - 51.
Gadwal S, Korotkov KV, Delarosa JR, Hol WG, Sandkvist M. Functional and structural characterization of Vibrio cholerae extracellular serine protease B, VesB. J Biol Chem. 2014;289(12):8288-8298 - 52.
Syngkon A, Elluri S, Koley H, Rompikuntal PK, Saha DR, Chakrabarti MK, et al. Studies on a novel serine protease of a DeltahapADeltaprtV Vibrio cholerae O1 strain and its role in hemorrhagic response in the rabbit ileal loop model. PLoS One. 2010;5(9) - 53.
Vaitkevicius K, Rompikuntal PK, Lindmark B, Vaitkevicius R, Song T, Wai SN. The metalloprotease PrtV from Vibrio cholerae . FEBS J. 2008;275(12):3167-3177 - 54.
Ogierman MA, Fallarino A, Riess T, Williams SG, Attridge SR, Manning PA. Characterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly region. J Bacteriol. 1997;179(22):7072-7080 - 55.
Edwin A, Grundstrom C, Wai SN, Ohman A, Stier G, Sauer-Eriksson AE. Domain isolation, expression, purification and proteolytic activity of the metalloprotease PrtV from Vibrio cholerae . Protein Expr Purif. 2014;96:39-47 - 56.
Rompikuntal PK, Vdovikova S, Duperthuy M, Johnson TL, Ahlund M, Lundmark R, et al. Outer Membrane Vesicle-Mediated Export of Processed PrtV Protease from Vibrio cholerae . PLoS One. 2015;10(7):e0134098 - 57.
Vaitkevicius K, Lindmark B, Ou G, Song T, Toma C, Iwanaga M, et al. A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A. 2006;103(24):9280-9285 - 58.
Edwin A, Persson C, Mayzel M, Wai SN, Ohman A, Karlsson BG, et al. Structure of the N-terminal domain of the metalloprotease PrtV from Vibrio cholerae . Protein Sci. 2015;24(12):2076-2080 - 59.
Stoebner JA, Payne SM. Iron-regulated hemolysin production and utilization of heme and hemoglobin by Vibrio cholerae . Infect Immun. 1988;56(11):2891-2895 - 60.
Debellis L, Diana A, Arcidiacono D, Fiorotto R, Portincasa P, Altomare DF, et al. The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One. 2009;4(3):e5074 - 61.
Toma C, Honma Y. Cloning and genetic analysis of the Vibrio cholerae aminopeptidase gene. Infect Immun. 1996;64(11):4495-4500 - 62.
Seper A, Hosseinzadeh A, Gorkiewicz G, Lichtenegger S, Roier S, Leitner DR, et al. Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog. 2013;9(9):e1003614 - 63.
Blokesch M, Schoolnik GK. The extracellular nuclease Dns and its role in natural transformation of Vibrio cholerae . J Bacteriol. 2008;190(21):7232-7240 - 64.
Joshi A, Kostiuk B, Rogers A, Teschler J, Pukatzki S, Yildiz FH. Rules of Engagement: The Type VI Secretion System in Vibrio cholerae . Trends Microbiol. 2017;25(4):267-279 - 65.
Coulthurst S. The Type VI secretion system: a versatile bacterial weapon. Microbiology (Reading). 2019;165(5):503-515 - 66.
Cherrak Y, Flaugnatti N, Durand E, Journet L, Cascales E. Structure and Activity of the Type VI Secretion System. Microbiol Spectr. 2019;7(4) - 67.
Borgeaud S, Metzger LC, Scrignari T, Blokesch M. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer. Science. 2015;347(6217):63-67 - 68.
Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A. 2006;103(5):1528-1533 - 69.
Shneider MM, Buth SA, Ho BT, Basler M, Mekalanos JJ, Leiman PG. PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature. 2013;500(7462):350-353 - 70.
Brunet YR, Henin J, Celia H, Cascales E. Type VI secretion and bacteriophage tail tubes share a common assembly pathway. EMBO Rep. 2014;15(3):315-321 - 71.
Kube S, Kapitein N, Zimniak T, Herzog F, Mogk A, Wendler P. Structure of the VipA/B type VI secretion complex suggests a contraction-state-specific recycling mechanism. Cell Rep. 2014;8(1):20-30 - 72.
Bonemann G, Pietrosiuk A, Diemand A, Zentgraf H, Mogk A. Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J. 2009;28(4):315-325 - 73.
Pietrosiuk A, Lenherr ED, Falk S, Bonemann G, Kopp J, Zentgraf H, et al. Molecular basis for the unique role of the AAA+ chaperone ClpV in type VI protein secretion. J Biol Chem. 2011;286(34):30010-30021 - 74.
Unterweger D, Kostiuk B, Pukatzki S. Adaptor Proteins of Type VI Secretion System Effectors. Trends Microbiol. 2017;25(1):8-10 - 75.
Crisan CV, Chande AT, Williams K, Raghuram V, Rishishwar L, Steinbach G, et al. Analysis of Vibrio cholerae genomes identifies new type VI secretion system gene clusters. Genome Biol. 2019;20(1):163 - 76.
Labbate M, Orata FD, Petty NK, Jayatilleke ND, King WL, Kirchberger PC, et al. A genomic island in Vibrio cholerae with VPI-1 site-specific recombination characteristics contains CRISPR-Cas and type VI secretion modules. Sci Rep. 2016;6:36891 - 77.
Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, et al. The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. Nat Commun. 2014;5:3549 - 78.
Dong TG, Mekalanos JJ. Characterization of the RpoN regulon reveals differential regulation of T6SS and new flagellar operons in Vibrio cholerae O37 strain V52. Nucleic Acids Res. 2012;40(16):7766-7775 - 79.
Ishikawa T, Sabharwal D, Broms J, Milton DL, Sjostedt A, Uhlin BE, et al. Pathoadaptive conditional regulation of the type VI secretion system in Vibrio cholerae O1 strains. Infect Immun. 2012;80(2):575-584 - 80.
Drebes Dorr NC, Blokesch M. Interbacterial competition and anti-predatory behaviour of environmental Vibrio cholerae strains. Environ Microbiol. 2020;22(10):4485-4504 - 81.
Yang X, Long M, Shen X. Effector(-)Immunity Pairs Provide the T6SS Nanomachine its Offensive and Defensive Capabilities. Molecules. 2018;23(5) - 82.
Vettiger A, Basler M. Type VI Secretion System Substrates Are Transferred and Reused among Sister Cells. Cell. 2016;167(1):99-110 e12 - 83.
Silverman JM, Agnello DM, Zheng H, Andrews BT, Li M, Catalano CE, et al. Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. Mol Cell. 2013;51(5):584-593 - 84.
Williams SG, Varcoe LT, Attridge SR, Manning PA. Vibrio cholerae Hcp, a secreted protein coregulated with HlyA. Infect Immun. 1996;64(1):283-289 - 85.
Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A. 2007;104(39):15508-15513 - 86.
Ma AT, Mekalanos JJ. In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A. 2010;107(9):4365-4370 - 87.
Brooks TM, Unterweger D, Bachmann V, Kostiuk B, Pukatzki S. Lytic activity of the Vibrio cholerae type VI secretion toxin VgrG-3 is inhibited by the antitoxin TsaB. J Biol Chem. 2013;288(11):7618-7625 - 88.
Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ. Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae . Proc Natl Acad Sci U S A. 2013;110(7):2623-2628 - 89.
Miyata ST, Kitaoka M, Brooks TM, McAuley SB, Pukatzki S. Vibrio cholerae requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect Immun. 2011;79(7):2941-2949 - 90.
Miyata ST, Unterweger D, Rudko SP, Pukatzki S. Dual expression profile of type VI secretion system immunity genes protects pandemic Vibrio cholerae . PLoS Pathog. 2013;9(12):e1003752 - 91.
Kamal F, Liang X, Manera K, Pei TT, Kim H, Lam LG, et al. Differential Cellular Response to Translocated Toxic Effectors and Physical Penetration by the Type VI Secretion System. Cell Rep. 2020;31(11):107766 - 92.
Altindis E, Dong T, Catalano C, Mekalanos J. Secretome analysis of Vibrio cholerae type VI secretion system reveals a new effector-immunity pair. mBio. 2015;6(2):e00075 - 93.
Kostiuk B, Unterweger D, Provenzano D, Pukatzki S. T6SS intraspecific competition orchestrates Vibrio cholerae genotypic diversity. Int Microbiol. 2017;20(3):130-137 - 94.
Kanonenberg K, Spitz O, Erenburg IN, Beer T, Schmitt L. Type I secretion system-it takes three and a substrate. FEMS Microbiol Lett. 2018;365(11) - 95.
Gray L, Mackman N, Nicaud JM, Holland IB. The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol Gen Genet. 1986;205(1):127-133 - 96.
Costa TR, Felisberto-Rodrigues C, Meir A, Prevost MS, Redzej A, Trokter M, et al. Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev Microbiol. 2015;13(6):343-359 - 97.
Boardman BK, Satchell KJ. Vibrio cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol. 2004;186(23):8137-8143 - 98.
Boardman BK, Meehan BM, Fullner Satchell KJ. Growth phase regulation of Vibrio cholerae RTX toxin export. J Bacteriol. 2007;189(5):1827-1835 - 99.
Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, et al. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev. 2010;34(6):1076-1112 - 100.
Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, et al. Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A. 1999;96(3):1071-1076 - 101.
Cordero CL, Kudryashov DS, Reisler E, Satchell KJ. The Actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin. J Biol Chem. 2006;281(43):32366-32374 - 102.
Cordero CL, Sozhamannan S, Satchell KJ. RTX toxin actin cross-linking activity in clinical and environmental isolates of Vibrio cholerae . J Clin Microbiol. 2007;45(7):2289-2292 - 103.
Fullner KJ, Mekalanos JJ. In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J. 2000;19(20):5315-5323 - 104.
Sheahan KL, Cordero CL, Satchell KJ. Identification of a domain within the multifunctional Vibrio cholerae RTX toxin that covalently cross-links actin. Proc Natl Acad Sci U S A. 2004;101(26):9798-9803 - 105.
Chatterjee R, Nag S, Chaudhuri K. Identification of a new RTX-like gene cluster in Vibrio cholerae . FEMS Microbiol Lett. 2008;284(2):165-171 - 106.
Syed KA, Beyhan S, Correa N, Queen J, Liu J, Peng F, et al. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol. 2009;191(21):6555-6570 - 107.
Syed KA. Regulation of hemagglutinin by flagellar hierarchy in Vibrio cholerae . Ann Arbor: University of Texas; 2010 - 108.
Kitts G, Giglio KM, Zamorano-Sanchez D, Park JH, Townsley L, Cooley RB, et al. A Conserved Regulatory Circuit Controls Large Adhesins in Vibrio cholerae . mBio. 2019;10(6) - 109.
Miller KA, Tomberlin KF, Dziejman M. Vibrio variations on a type three theme. Curr Opin Microbiol. 2019;47:66-73 - 110.
Chaand M, Miller KA, Sofia MK, Schlesener C, Weaver JW, Sood V, et al. Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup Vibrio cholerae . Infect Immun. 2015;83(7):2862-2869 - 111.
Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, et al. Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A. 2005;102(9):3465-3470 - 112.
Shin OS, Tam VC, Suzuki M, Ritchie JM, Bronson RT, Waldor MK, et al. Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae . mBio. 2011;2(3):e00106-11 - 113.
Portaliou AG, Tsolis KC, Loos MS, Zorzini V, Economou A. Type III Secretion: Building and Operating a Remarkable Nanomachine. Trends Biochem Sci. 2016;41(2):175-189 - 114.
Alam A, Miller KA, Chaand M, Butler JS, Dziejman M. Identification of Vibrio cholerae type III secretion system effector proteins. Infect Immun. 2011;79(4):1728-1740 - 115.
Morita M, Yamamoto S, Hiyoshi H, Kodama T, Okura M, Arakawa E, et al. Horizontal gene transfer of a genetic island encoding a type III secretion system distributed in Vibrio cholerae . Microbiol Immunol. 2013;57(5):334-339 - 116.
Alam A, Tam V, Hamilton E, Dziejman M. vttRA and vttRB Encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/non-O139 Vibrio cholerae strain. Infect Immun. 2010;78(6):2554-2570 - 117.
Miller KA, Sofia MK, Weaver JWA, Seward CH, Dziejman M. Regulation by ToxR-Like Proteins Converges on vttRB Expression To Control Type 3 Secretion System-Dependent Caco2-BBE Cytotoxicity in Vibrio cholerae . J Bacteriol. 2016;198(11):1675-1682 - 118.
Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ. A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe. 2007;1(2):95-107 - 119.
Tam VC, Suzuki M, Coughlin M, Saslowsky D, Biswas K, Lencer WI, et al. Functional analysis of VopF activity required for colonization in Vibrio cholerae . mBio. 2010;1(5) - 120.
Seward CH, Manzella A, Alam A, Butler JS, Dziejman M. Using S. cerevisiae as a Model System to Investigate V. cholerae VopX-Host Cell Protein Interactions and Phenotypes. Toxins (Basel). 2015;7(10):4099-4110 - 121.
Suzuki M, Danilchanka O, Mekalanos JJ. Vibrio cholerae T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe. 2014;16(5):581-591 - 122.
Kay LJ, Sangal V, Black GW, Soundararajan M. Proteomics and bioinformatics analyses identify novel cellular roles outside mitochondrial function for human miro GTPases. Mol Cell Biochem. 2019;451(1-2):21-35 - 123.
Hospenthal MK, Costa TRD, Waksman G. A comprehensive guide to pilus biogenesis in Gram-negative bacteria. Nat Rev Microbiol. 2017;15(6):365-379 - 124.
Lim MS, Ng D, Zong Z, Arvai AS, Taylor RK, Tainer JA, et al. Vibrio cholerae El Tor TcpA crystal structure and mechanism for pilus-mediated microcolony formation. Mol Microbiol. 2010;77(3):755-770 - 125.
Kumar A, Das B, Kumar N. Vibrio Pathogenicity Island-1: The Master Determinant of Cholera Pathogenesis. Front Cell Infect Microbiol. 2020;10:561296 - 126.
Tacket CO, Taylor RK, Losonsky G, Lim Y, Nataro JP, Kaper JB, et al. Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun. 1998;66(2):692-695 - 127.
Gutierrez-Rodarte M, Kolappan S, Burrell BA, Craig L. The Vibrio cholerae minor pilin TcpB mediates uptake of the cholera toxin phage CTXphi. J Biol Chem. 2019;294(43):15698-15710 - 128.
Watnick PI, Fullner KJ, Kolter R. A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor. J Bacteriol. 1999;181(11):3606-3609 - 129.
Floyd KA, Lee CK, Xian W, Nametalla M, Valentine A, Crair B, et al. c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae . Nat Commun. 2020;11(1):1549 - 130.
Fullner KJ, Mekalanos JJ. Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae . Infect Immun. 1999;67(3):1393-1404 - 131.
Adams DW, Stutzmann S, Stoudmann C, Blokesch M. DNA-uptake pili of Vibrio cholerae are required for chitin colonization and capable of kin recognition via sequence-specific self-interaction. Nat Microbiol. 2019;4(9):1545-1557 - 132.
Shime-Hattori A, Iida T, Arita M, Park KS, Kodama T, Honda T. Two type IV pili of Vibrio parahaemolyticus play different roles in biofilm formation. FEMS Microbiol Lett. 2006;264(1):89-97 - 133.
Ogura K, Yahiro K, Moss J. Cell Death Signaling Pathway Induced by Cholix Toxin, a Cytotoxin and eEF2 ADP-Ribosyltransferase Produced by Vibrio cholerae . Toxins (Basel). 2020;13(1) - 134.
Jorgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae . J Biol Chem. 2008;283(16):10671-10678 - 135.
Taverner A, MacKay J, Laurent F, Hunter T, Liu K, Mangat K, et al. Cholix protein domain I functions as a carrier element for efficient apical to basal epithelial transcytosis. Tissue Barriers. 2020;8(1):1710429 - 136.
Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A. 1993;90(11):5267-5271 - 137.
Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A. 1991;88(12):5242-5246 - 138.
Perez-Reytor D, Pavon A, Lopez-Joven C, Ramirez-Araya S, Pena-Varas C, Plaza N, et al. Analysis of the Zonula occludens Toxin Found in the Genome of the Chilean Non-toxigenic Vibrio parahaemolyticus Strain PMC53.7. Front Cell Infect Microbiol. 2020;10:482 - 139.
Uzzau S, Cappuccinelli P, Fasano A. Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization. Microb Pathog. 1999;27(6):377-385 - 140.
Goldblum SE, Rai U, Tripathi A, Thakar M, De Leo L, Di Toro N, et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J. 2011;25(1):144-158 - 141.
Guerrero-Mandujano A, Hernandez-Cortez C, Ibarra JA, Castro-Escarpulli G. The outer membrane vesicles: Secretion system type zero. Traffic. 2017;18(7):425-432 - 142.
Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17(1):13-24 - 143.
Altindis E, Fu Y, Mekalanos JJ. Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc Natl Acad Sci U S A. 2014;111(15):E1548-E1556 - 144.
Langlete P, Krabberod AK, Winther-Larsen HC. Vesicles From Vibrio cholerae Contain AT-Rich DNA and Shorter mRNAs That Do Not Correlate With Their Protein Products. Front Microbiol. 2019;10:2708 - 145.
Sjostrom AE, Sandblad L, Uhlin BE, Wai SN. Membrane vesicle-mediated release of bacterial RNA. Sci Rep. 2015;5:15329 - 146.
Zingl FG, Kohl P, Cakar F, Leitner DR, Mitterer F, Bonnington KE, et al. Outer Membrane Vesiculation Facilitates Surface Exchange and In Vivo Adaptation of Vibrio cholerae . Cell Host Microbe. 2020;27(2):225-237 e8 - 147.
Orench-Rivera N, Kuehn MJ. Environmentally controlled bacterial vesicle-mediated export. Cell Microbiol. 2016;18(11):1525-1536 - 148.
Duperthuy M, Sjostrom AE, Sabharwal D, Damghani F, Uhlin BE, Wai SN. Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides. PLoS Pathog. 2013;9(10):e1003620 - 149.
Miller VL, Mekalanos JJ. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988;170(6):2575-2583 - 150.
Champion GA, Neely MN, Brennan MA, DiRita VJ. A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains. Mol Microbiol. 1997;23(2):323-331 - 151.
Mathur J, Waldor MK. The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides. Infect Immun. 2004;72(6):3577-3583 - 152.
Blake PA, Weaver RE, Hollis DG. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341-367 - 153.
Aung KM, Sjostrom AE, von Pawel-Rammingen U, Riesbeck K, Uhlin BE, Wai SN. Naturally Occurring IgG Antibodies Provide Innate Protection against Vibrio cholerae Bacteremia by Recognition of the Outer Membrane Protein U. J Innate Immun. 2016;8(3):269-283 - 154.
Reyes-Robles T, Dillard RS, Cairns LS, Silva-Valenzuela CA, Housman M, Ali A, et al. Vibrio cholerae Outer Membrane Vesicles Inhibit Bacteriophage Infection. J Bacteriol. 2018;200(15) - 155.
Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061-1072 - 156.
Fong JNC, Yildiz FH. Biofilm Matrix Proteins. Microbiol Spectr. 2015;3(2) - 157.
Chatterjee D, Chaudhuri K. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett. 2011;585(9):1357-1362 - 158.
Rasti ES, Brown AC. Cholera Toxin Encapsulated within Several Vibrio cholerae O1 Serotype Inaba Outer Membrane Vesicles Lacks a Functional B-Subunit. Toxins (Basel). 2019;11(4) - 159.
O'Donoghue EJ, Krachler AM. Mechanisms of outer membrane vesicle entry into host cells. Cell Microbiol. 2016;18(11):1508-1517 - 160.
Mondal A, Tapader R, Chatterjee NS, Ghosh A, Sinha R, Koley H, et al. Cytotoxic and Inflammatory Responses Induced by Outer Membrane Vesicle-Associated Biologically Active Proteases from Vibrio cholerae . Infect Immun. 2016;84(5):1478-1490 - 161.
Elluri S, Enow C, Vdovikova S, Rompikuntal PK, Dongre M, Carlsson S, et al. Outer membrane vesicles mediate transport of biologically active Vibrio cholerae cytolysin (VCC) from V. cholerae strains. PLoS One. 2014;9(9):e106731 - 162.
Silva AJ, Benitez JA. Vibrio cholerae Biofilms and Cholera Pathogenesis. PLoS Negl Trop Dis. 2016;10(2):e0004330 - 163.
Lutz C, Erken M, Noorian P, Sun S, McDougald D. Environmental reservoirs and mechanisms of persistence of Vibrio cholerae . Front Microbiol. 2013;4:375 - 164.
Conner JG, Teschler JK, Jones CJ, Yildiz FH. Staying Alive: Vibrio cholerae’s Cycle of Environmental Survival, Transmission, and Dissemination. Microbiol Spectr. 2016;4(2) - 165.
Echazarreta MA, Klose KE. Vibrio Flagellar Synthesis. Front Cell Infect Microbiol. 2019;9:131 - 166.
Galan JE, Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science. 1999;284(5418):1322-1328 - 167.
Klose KE, Mekalanos JJ. Differential regulation of multiple flagellins in Vibrio cholerae . J Bacteriol. 1998;180(2):303-316 - 168.
Dongre M, Singh B, Aung KM, Larsson P, Miftakhova R, Persson K, et al. Flagella-mediated secretion of a novel Vibrio cholerae cytotoxin affecting both vertebrate and invertebrate hosts. Commun Biol. 2018;1:59 - 169.
Butler SM, Camilli A. Both chemotaxis and net motility greatly influence the infectivity of Vibrio cholerae . Proc Natl Acad Sci U S A. 2004;101(14):5018-5023 - 170.
Utada AS, Bennett RR, Fong JCN, Gibiansky ML, Yildiz FH, Golestanian R, et al. Vibrio cholerae use pili and flagella synergistically to effect motility switching and conditional surface attachment. Nat Commun. 2014;5:4913 - 171.
Lauriano CM, Ghosh C, Correa NE, Klose KE. The sodium-driven flagellar motor controls exopolysaccharide expression in Vibrio cholerae . J Bacteriol. 2004;186(15):4864-4874 - 172.
Yildiz F, Fong J, Sadovskaya I, Grard T, Vinogradov E. Structural characterization of the extracellular polysaccharide from Vibrio cholerae O1 El-Tor. PLoS One. 2014;9(1):e86751 - 173.
Yildiz FH, Schoolnik GK. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci U S A. 1999;96(7):4028-4033 - 174.
Fong JCN, Syed KA, Klose KE, Yildiz FH. Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and Vibrio cholerae pathogenesis. Microbiology (Reading). 2010;156(Pt 9):2757-2769 - 175.
Schwechheimer C, Hebert K, Tripathi S, Singh PK, Floyd KA, Brown ER, et al. A tyrosine phosphoregulatory system controls exopolysaccharide biosynthesis and biofilm formation in Vibrio cholerae . PLoS Pathog. 2020;16(8):e1008745 - 176.
Teschler JK, Zamorano-Sanchez D, Utada AS, Warner CJ, Wong GC, Linington RG, et al. Living in the matrix: assembly and control of Vibrio cholerae biofilms. Nat Rev Microbiol. 2015;13(5):255-268 - 177.
Fong JC, Yildiz FH. The rbmBCDEF gene cluster modulates development of rugose colony morphology and biofilm formation in Vibrio cholerae . J Bacteriol. 2007;189(6):2319-2330 - 178.
Kaus K, Biester A, Chupp E, Lu J, Visudharomn C, Olson R. The 1.9 A crystal structure of the extracellular matrix protein Bap1 from Vibrio cholerae provides insights into bacterial biofilm adhesion. J Biol Chem. 2019;294(40):14499-14511 - 179.
Fong JC, Karplus K, Schoolnik GK, Yildiz FH. Identification and characterization of RbmA, a novel protein required for the development of rugose colony morphology and biofilm structure in Vibrio cholerae . J Bacteriol. 2006;188(3):1049-1059 - 180.
Smith DR, Maestre-Reyna M, Lee G, Gerard H, Wang AH, Watnick PI. In situ proteolysis of the Vibrio cholerae matrix protein RbmA promotes biofilm recruitment. Proc Natl Acad Sci U S A. 2015;112(33):10491-10496 - 181.
Duperthuy M, Uhlin BE, Wai SN. Biofilm recruitment of Vibrio cholerae by matrix proteolysis. Trends Microbiol. 2015;23(11):667-668 - 182.
Absalon C, Van Dellen K, Watnick PI. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 2011;7(8):e1002210 - 183.
Vorkapic D, Pressler K, Schild S. Multifaceted roles of extracellular DNA in bacterial physiology. Curr Genet. 2016;62(1):71-79 - 184.
Kanampalliwar A, Singh DV. Extracellular DNA builds and interacts with vibrio polysaccharide in the biofilm matrix formed by Vibrio cholerae . Environ Microbiol Rep. 2020;12(5):594-606 - 185.
Seper A, Fengler VH, Roier S, Wolinski H, Kohlwein SD, Bishop AL, et al. Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol. 2011;82(4):1015-1037 - 186.
Kaplan JB. Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J Dent Res. 2010;89(3):205-218 - 187.
Singh PK, Bartalomej S, Hartmann R, Jeckel H, Vidakovic L, Nadell CD, et al. Vibrio cholerae Combines Individual and Collective Sensing to Trigger Biofilm Dispersal. Curr Biol. 2017;27(21):3359-3366 e7 - 188.
Bridges AA, Fei C, Bassler BL. Identification of signaling pathways, matrix-digestion enzymes, and motility components controlling Vibrio cholerae biofilm dispersal. Proc Natl Acad Sci U S A. 2020;117(51):32639-32647 - 189.
Mewborn L, Benitez JA, Silva AJ. Flagellar motility, extracellular proteases and Vibrio cholerae detachment from abiotic and biotic surfaces. Microb Pathog. 2017;113:17-24